Pfizer Inks $25M Deal Ending Leftover Effexor Antitrust Claims

By Lauren Berg · April 29, 2024, 11:08 PM EDT

A proposed class of indirect buyers have asked a New Jersey federal judge to greenlight a $25.5 million settlement to end allegations that Pfizer unit Wyeth engaged in a scheme with...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

PROFESSIONAL DRUG COMPANY, INC. v. WYETH, INC.

Case Number

Court

New Jersey

Nature of Suit

Anti-Trust

Date Filed

September 22, 2011

Recent Articles By Lauren

October 30, 2024
FDA Didn't Flub Approval In Orphan Drug Case, DC Court Says
October 18, 2024
Oklahoma Brings Title X Funding Cut Fight To Justices
October 11, 2024
Feds Target Ill. Hospital CEO As $19M Theft Probe Widens
October 11, 2024
Quinn Emanuel Gets Trimmed $92M Fee In ACA Cases
September 30, 2024
Takeda End Payors, Direct Buyers Win Antitrust Class Cert.
September 30, 2024
Bristol-Myers Beats Celgene Investors' Drug Delay Suit
September 27, 2024
9th Circ. Says Stem Cell Treatment Not Exempt From FDA Rule
August 30, 2024
McKesson, Others To Pay Benefit Plans $300M In Opioid Deal
August 23, 2024
NY Can't Sue Groups Over Abortion 'Reversal' Ads, For Now
August 21, 2024
Fed. Circ. Won't Rethink IP Safe Harbor Case